Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease

There is an urgent need for biomarkers in plasma to identify Alzheimer's disease (AD). It has previously been shown that a signature of 18 plasma proteins can identify AD during pre-dementia and dementia stages (Ray et al, Nature Medicine, 2007). We quantified the same 18 proteins in plasma from 174 controls, 142 patients with AD, and 88 patients with other dementias. Only three of these proteins (EGF, PDG-BB and MIP-1δ) differed significantly in plasma between controls and AD. The 18 proteins could classify patients with AD from controls with low diagnostic precision (area under the ROC curve was 63%). Moreover, they could not distinguish AD from other dementias. In conclusion, independent validation of results is important in explorative biomarker studies

Manganoan garnet rocks associated with the Broken Hill Pb-Zn-Ag Orebody, Australia

The original publication is available at www.springerlink.comThe Palaeoproterozoic Broken Hill Pb–Zn–Ag stratiform orebody is intimately associated with manganoan garnet-bearing rocks. On stratigraphic and chemical grounds it is argued that garnet-rich metasediments below, equivalent to and above massive sulphide were hydrothermal precipitates. Other manganoan garnet rocks formed during pre-metamorphic hydrothermal alteration, syn-metamorphic dehydration and reaction of manganese with prograde pelitic rocks, reaction between cataclastic manganese-bearing sulphide rocks injected along axial planes, shears and faults and pelitic wall rocks and reaction between dolerite dykes and sulphide rocks